nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.0317	0.0317	CcSEcCtD
Betaxolol—Sleep disturbance—Hydrochlorothiazide—nephrolithiasis	0.0298	0.0298	CcSEcCtD
Betaxolol—Respiratory distress—Hydrochlorothiazide—nephrolithiasis	0.0263	0.0263	CcSEcCtD
Betaxolol—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.0232	0.0232	CcSEcCtD
Betaxolol—Numbness—Hydrochlorothiazide—nephrolithiasis	0.0201	0.0201	CcSEcCtD
Betaxolol—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.0193	0.0193	CcSEcCtD
Betaxolol—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.018	0.018	CcSEcCtD
Betaxolol—Gout—Hydrochlorothiazide—nephrolithiasis	0.0179	0.0179	CcSEcCtD
Betaxolol—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0176	0.0176	CcSEcCtD
Betaxolol—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.017	0.017	CcSEcCtD
Betaxolol—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.0164	0.0164	CcSEcCtD
Betaxolol—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.014	0.014	CcSEcCtD
Betaxolol—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.0139	0.0139	CcSEcCtD
Betaxolol—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0135	CcSEcCtD
Betaxolol—Injury—Hydrochlorothiazide—nephrolithiasis	0.0132	0.0132	CcSEcCtD
Betaxolol—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0131	CcSEcCtD
Betaxolol—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.0129	0.0129	CcSEcCtD
Betaxolol—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0127	CcSEcCtD
Betaxolol—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0127	CcSEcCtD
Betaxolol—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0126	CcSEcCtD
Betaxolol—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0125	CcSEcCtD
Betaxolol—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.012	0.012	CcSEcCtD
Betaxolol—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0119	CcSEcCtD
Betaxolol—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0115	CcSEcCtD
Betaxolol—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0114	CcSEcCtD
Betaxolol—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.011	0.011	CcSEcCtD
Betaxolol—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0109	CcSEcCtD
Betaxolol—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0109	CcSEcCtD
Betaxolol—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0109	CcSEcCtD
Betaxolol—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0109	CcSEcCtD
Betaxolol—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0107	CcSEcCtD
Betaxolol—Influenza—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0105	CcSEcCtD
Betaxolol—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0105	CcSEcCtD
Betaxolol—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0102	CcSEcCtD
Betaxolol—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00979	0.00979	CcSEcCtD
Betaxolol—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00973	0.00973	CcSEcCtD
Betaxolol—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00965	0.00965	CcSEcCtD
Betaxolol—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00953	0.00953	CcSEcCtD
Betaxolol—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00945	0.00945	CcSEcCtD
Betaxolol—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00939	0.00939	CcSEcCtD
Betaxolol—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00921	0.00921	CcSEcCtD
Betaxolol—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00915	0.00915	CcSEcCtD
Betaxolol—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00915	0.00915	CcSEcCtD
Betaxolol—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00908	0.00908	CcSEcCtD
Betaxolol—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00895	0.00895	CcSEcCtD
Betaxolol—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00881	0.00881	CcSEcCtD
Betaxolol—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00876	0.00876	CcSEcCtD
Betaxolol—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00871	0.00871	CcSEcCtD
Betaxolol—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00853	0.00853	CcSEcCtD
Betaxolol—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.0084	0.0084	CcSEcCtD
Betaxolol—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00834	0.00834	CcSEcCtD
Betaxolol—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00832	0.00832	CcSEcCtD
Betaxolol—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00808	0.00808	CcSEcCtD
Betaxolol—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00782	0.00782	CcSEcCtD
Betaxolol—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00778	0.00778	CcSEcCtD
Betaxolol—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00749	0.00749	CcSEcCtD
Betaxolol—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00741	0.00741	CcSEcCtD
Betaxolol—Erythema—Hydrochlorothiazide—nephrolithiasis	0.0073	0.0073	CcSEcCtD
Betaxolol—Tension—Hydrochlorothiazide—nephrolithiasis	0.00716	0.00716	CcSEcCtD
Betaxolol—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00715	0.00715	CcSEcCtD
Betaxolol—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00709	0.00709	CcSEcCtD
Betaxolol—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00702	0.00702	CcSEcCtD
Betaxolol—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00688	0.00688	CcSEcCtD
Betaxolol—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00684	0.00684	CcSEcCtD
Betaxolol—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00677	0.00677	CcSEcCtD
Betaxolol—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00674	0.00674	CcSEcCtD
Betaxolol—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00658	0.00658	CcSEcCtD
Betaxolol—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00656	0.00656	CcSEcCtD
Betaxolol—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00654	0.00654	CcSEcCtD
Betaxolol—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00645	0.00645	CcSEcCtD
Betaxolol—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00641	0.00641	CcSEcCtD
Betaxolol—Cough—Hydrochlorothiazide—nephrolithiasis	0.00637	0.00637	CcSEcCtD
Betaxolol—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00621	0.00621	CcSEcCtD
Betaxolol—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00621	0.00621	CcSEcCtD
Betaxolol—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00621	0.00621	CcSEcCtD
Betaxolol—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00619	0.00619	CcSEcCtD
Betaxolol—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00614	0.00614	CcSEcCtD
Betaxolol—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00608	0.00608	CcSEcCtD
Betaxolol—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.006	0.006	CcSEcCtD
Betaxolol—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00596	0.00596	CcSEcCtD
Betaxolol—Shock—Hydrochlorothiazide—nephrolithiasis	0.00586	0.00586	CcSEcCtD
Betaxolol—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00583	0.00583	CcSEcCtD
Betaxolol—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00581	0.00581	CcSEcCtD
Betaxolol—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00576	0.00576	CcSEcCtD
Betaxolol—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00568	0.00568	CcSEcCtD
Betaxolol—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00556	0.00556	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00543	0.00543	CcSEcCtD
Betaxolol—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00539	0.00539	CcSEcCtD
Betaxolol—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00535	0.00535	CcSEcCtD
Betaxolol—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00531	0.00531	CcSEcCtD
Betaxolol—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00524	0.00524	CcSEcCtD
Betaxolol—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00518	0.00518	CcSEcCtD
Betaxolol—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00513	0.00513	CcSEcCtD
Betaxolol—Pain—Hydrochlorothiazide—nephrolithiasis	0.00509	0.00509	CcSEcCtD
Betaxolol—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00509	0.00509	CcSEcCtD
Betaxolol—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00491	0.00491	CcSEcCtD
Betaxolol—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00473	0.00473	CcSEcCtD
Betaxolol—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00471	0.00471	CcSEcCtD
Betaxolol—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00439	0.00439	CcSEcCtD
Betaxolol—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00427	0.00427	CcSEcCtD
Betaxolol—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00421	0.00421	CcSEcCtD
Betaxolol—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00407	0.00407	CcSEcCtD
Betaxolol—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00394	0.00394	CcSEcCtD
Betaxolol—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00379	0.00379	CcSEcCtD
Betaxolol—Rash—Hydrochlorothiazide—nephrolithiasis	0.00376	0.00376	CcSEcCtD
Betaxolol—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00375	0.00375	CcSEcCtD
Betaxolol—Headache—Hydrochlorothiazide—nephrolithiasis	0.00373	0.00373	CcSEcCtD
Betaxolol—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00354	0.00354	CcSEcCtD
